Published in Int J Nanomedicine on September 10, 2015
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul (2001) 6.59
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev (2010) 5.26
Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev (2010) 3.30
Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest (2013) 2.83
Drug targeting. Eur J Pharm Sci (2000) 1.91
Pegloticase. Nat Rev Drug Discov (2011) 1.76
Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats. J Am Coll Cardiol (2009) 1.71
Angiogenesis in ischemic heart disease. Nat Med (1997) 1.46
Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits. J Control Release (2004) 1.19
Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J (2009) 1.11
ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction. Pharm Res (2005) 1.10
Nanoparticles targeting the infarcted heart. Nano Lett (2011) 1.03
Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes. Nat Med (1995) 0.97
Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol (2012) 0.94
A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart. Glycobiology (2009) 0.91
Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery. J Control Release (2012) 0.91
[Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon japonicus]. Yao Xue Xue Bao (2005) 0.90
Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury. J Mol Cell Cardiol (2005) 0.90
Time course of coronary endothelial healing after injury due to ischemia and reperfusion. Circulation (1994) 0.89
Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue. Expert Opin Drug Deliv (2008) 0.88
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction. Pharm Res (2007) 0.88
Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity. Eur J Pharm Biopharm (2010) 0.86
A new technique of coronary artery ligation: experimental myocardial infarction in rats in vivo with reduced mortality. Mol Cell Biochem (1997) 0.86
Determination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization. Anal Biochem (2005) 0.85
Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. Cardiovasc Drugs Ther (2013) 0.84
Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium. Eur J Pharm Biopharm (2011) 0.83
Influence of sulfation on anti-myocardial ischemic activity of Ophiopogon japonicus polysaccharide. J Asian Nat Prod Res (2009) 0.83
A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats. Biomed Chromatogr (2010) 0.83
Delivery of lipid micelles into infarcted myocardium using a lipid-linked matrix metalloproteinase targeting peptide. Mol Pharm (2015) 0.83
Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int J Nanomedicine (2012) 0.82
Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. Eur J Pharm Sci (2013) 0.81
Cytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viability. J Control Release (2007) 0.80
Liposomes for cardiovascular targeting. Ther Deliv (2012) 0.78
PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium. Eur J Pharm Sci (2012) 0.78
[Mechanisms and strategies for targeting drugs to myocardial ischemic regions]. Yao Xue Xue Bao (2010) 0.78
Myocardial protection from ischemia-reperfusion injury post coronary revascularization. Expert Rev Cardiovasc Ther (2015) 0.78
Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats. Int J Nanomedicine (2015) 0.77
Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot. Int J Nanomedicine (2014) 0.75